Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cumberland Pharmaceuticals (CPIX) Accumulated Depreciation & Amortization (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 15.45% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 15.45% year-over-year, with the annual reading at $4.1 million for FY2025, 15.45% down from the prior year.
  • Accumulated Depreciation & Amortization hit $4.1 million in Q4 2025 for Cumberland Pharmaceuticals, down from $4.9 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.3 million in Q4 2022 to a low of $4.1 million in Q4 2025.
  • Historically, Accumulated Depreciation & Amortization has averaged $4.8 million across 5 years, with a median of $4.9 million in 2024.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 15.67% in 2022 and later fell 15.45% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $4.6 million in 2021, then increased by 15.67% to $5.3 million in 2022, then decreased by 7.36% to $4.9 million in 2023, then dropped by 0.68% to $4.9 million in 2024, then dropped by 15.45% to $4.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for CPIX at $4.1 million in Q4 2025, $4.9 million in Q4 2024, and $4.9 million in Q4 2023.